Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages - Seite 2

 

For further information, please contact:

Kuros Biosciences AG	LifeSci Advisors
Daniel Geiger	Sandya von der Weid
Chief Financial Officer	Investors
t:  [phone]	t: [phone]
e: [e-mail]	e: [e-mail]

 

About MagnetOs
MagnetOs is a bone graft like no other: thanks to its NeedleGrip^TM surface technology, it grows bone even in soft tissues.* This surface technology provides traction for our body’s vitally important ‘pro-healing' immune cells (M2 macrophages).^†‡3,4 This in turn, unlocks previously untapped potential to stimulate stem cells - and form new bone throughout the graft.^†§5-8  The growing body of science behind NeedleGrip^TM is called osteoimmunology. But for surgeons and their patients it means one thing: a more predictable fusion.^†¶7,8

U.S. Indications Statement
MagnetOs Flex Matrix is intended to fill bony voids or gaps of the skeletal system, i.e., the intervertebral disc space, and posterolateral spine. The osseous defects may be surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. In the intervertebral disc space and posterolateral spine, MagnetOs Flex Matrix must be hydrated with bone marrow aspirate (BMA) and used as an extender to autograft bone. When used in interverterbral body fusion procedures, MagnetOs Flex Matrix must also be used with an intervertebral body fusion device cleared by FDA for use with a bone void filler.  MagnetOs Flex Matrix resorbs and is replaced with bone during the healing process.